company background image
300039 logo

Shanghai Kaibao PharmaceuticalLtd SZSE:300039 Stock Report

Last Price

CN¥6.00

Market Cap

CN¥6.3b

7D

-6.1%

1Y

-16.7%

Updated

13 Oct, 2024

Data

Company Financials

Shanghai Kaibao Pharmaceutical CO.,Ltd

SZSE:300039 Stock Report

Market Cap: CN¥6.3b

300039 Stock Overview

Engages in the research, development, production, and sale of modern Chinese medicines primarily in China.

300039 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance5/6
Financial Health6/6
Dividends3/6

Shanghai Kaibao Pharmaceutical CO.,Ltd Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Shanghai Kaibao PharmaceuticalLtd
Historical stock prices
Current Share PriceCN¥6.00
52 Week HighCN¥7.88
52 Week LowCN¥4.90
Beta0.25
11 Month Change18.34%
3 Month Change11.32%
1 Year Change-16.67%
33 Year Change30.72%
5 Year Change38.57%
Change since IPO28.42%

Recent News & Updates

A Piece Of The Puzzle Missing From Shanghai Kaibao Pharmaceutical CO.,Ltd's (SZSE:300039) Share Price

Jul 31
A Piece Of The Puzzle Missing From Shanghai Kaibao Pharmaceutical CO.,Ltd's (SZSE:300039) Share Price

Recent updates

A Piece Of The Puzzle Missing From Shanghai Kaibao Pharmaceutical CO.,Ltd's (SZSE:300039) Share Price

Jul 31
A Piece Of The Puzzle Missing From Shanghai Kaibao Pharmaceutical CO.,Ltd's (SZSE:300039) Share Price

Shareholder Returns

300039CN PharmaceuticalsCN Market
7D-6.1%-5.7%-4.5%
1Y-16.7%-8.5%-2.6%

Return vs Industry: 300039 underperformed the CN Pharmaceuticals industry which returned -8.5% over the past year.

Return vs Market: 300039 underperformed the CN Market which returned -2.6% over the past year.

Price Volatility

Is 300039's price volatile compared to industry and market?
300039 volatility
300039 Average Weekly Movement7.4%
Pharmaceuticals Industry Average Movement6.9%
Market Average Movement7.4%
10% most volatile stocks in CN Market11.2%
10% least volatile stocks in CN Market5.2%

Stable Share Price: 300039 has not had significant price volatility in the past 3 months compared to the CN market.

Volatility Over Time: 300039's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
20001,325n/awww.xykb.com

Shanghai Kaibao Pharmaceutical CO.,Ltd engages in the research, development, production, and sale of modern Chinese medicines primarily in China. Its primary products include Tanreqing injection for the treatment of pneumonia, acute and chronic bronchitis, and upper respiratory tract infection; Tanreqing capsules that clears heat and detoxifies and removes phlegm; tiopronin for injection, which improves liver function of various acute and chronic hepatitis; Tiopronin enteric-coated tablets for adjuvant treatment of chronic hepatitis; and Xiongdan dropping pills that clears heat, calms liver, and improves eyesight. The company was founded in 2000 and is based in Shanghai, China.

Shanghai Kaibao Pharmaceutical CO.,Ltd Fundamentals Summary

How do Shanghai Kaibao PharmaceuticalLtd's earnings and revenue compare to its market cap?
300039 fundamental statistics
Market capCN¥6.28b
Earnings (TTM)CN¥334.72m
Revenue (TTM)CN¥1.58b

18.7x

P/E Ratio

4.0x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
300039 income statement (TTM)
RevenueCN¥1.58b
Cost of RevenueCN¥284.14m
Gross ProfitCN¥1.29b
Other ExpensesCN¥957.99m
EarningsCN¥334.72m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

Oct 25, 2024

Earnings per share (EPS)0.32
Gross Margin81.98%
Net Profit Margin21.23%
Debt/Equity Ratio0%

How did 300039 perform over the long term?

See historical performance and comparison

Dividends

1.7%

Current Dividend Yield

31%

Payout Ratio